These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4755420)

  • 1. Effects of L-dopa and chlorpromazine on human growth hormone and TSH secretion in normal subjects and acromegalics.
    Singh P; McDevitt DG; Mackay J; Hadden DR
    Horm Res; 1973; 4(5):293-301. PubMed ID: 4755420
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of L-dopa on pituitary TSH and GH secretion in Parkinson's disease].
    Sakoda M; Kusaka T; Baba S; Shirakata S
    Nihon Naibunpi Gakkai Zasshi; 1972 Jul; 48(4):241-4. PubMed ID: 5066290
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacological control of growth hormone release. Studies on the action of L-dopa and chlorpromazine in normal subjects and patients with Parkinsonism, acromegaly and delayed onset of puberty.
    Singh P; McDevitt D; Mackay J; Hadden DR
    J Endocrinol; 1973 Jul; 58(1):xii. PubMed ID: 4722544
    [No Abstract]   [Full Text] [Related]  

  • 4. L-DOPA and pituitary hormone secretion.
    Hayek A; Crawford JD
    J Clin Endocrinol Metab; 1972 May; 34(5):764-6. PubMed ID: 5012491
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of L-dihydroxyphenylalanine upon serum growth hormone concentrations in children and adolescents.
    Root AW; Russ RD
    J Pediatr; 1972 Oct; 81(4):808-13. PubMed ID: 5074361
    [No Abstract]   [Full Text] [Related]  

  • 7. Abnormalities in the release of TSH in response to thyrotropin-releasing hormone (TRH) in patients with disorders of the pituitary, hypothalamus and basal ganglia.
    Schalch DS; Gonzalez-Barcena D; Kastin AJ; Schally AV; Lee LA
    J Clin Endocrinol Metab; 1972 Oct; 35(4):609-15. PubMed ID: 4626446
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretion of alpha and TSH-beta subunits in patients with acromegaly: an in vivo study.
    Assadian H; Shimatsu A; Koshiyama H; Hattori N; Ishikawa Y; Tanoh T; Imura H
    Acta Endocrinol (Copenh); 1990 Jun; 122(6):729-34. PubMed ID: 1695807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of human growth hormone, follicle stimulating hormone, and luteinizing hormone in response to L-dihydroxy-phenylalanine (L-dopa) in normal man.
    Perlow MJ; Sassin JF; Boyar R; Hellman L; Weitzman ED
    Dis Nerv Syst; 1972 Dec; 33(12):804-10. PubMed ID: 4668972
    [No Abstract]   [Full Text] [Related]  

  • 10. Responsiveness of growth hormone release in acromegalics after irradiation or hypophysectomy.
    Aida M; Hanew K; Tano T; Ojima M; Nishizato K
    Tohoku J Exp Med; 1976 Sep; 120(1):91-6. PubMed ID: 822535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a single dose of L-dopa on pituitary hormones in acromegaly, obesity, and in normal subjects.
    Mims RB; Stein RB; Bethune JE
    J Clin Endocrinol Metab; 1973 Jul; 37(1):34-9. PubMed ID: 4715294
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes of somatotropinemia in patients with acromegaly following administration of L-dopa].
    Chiodini PG; Liuzzi A; Cremascoli G; Botalla L
    Folia Endocrinol; 1973 Dec; 26(6):497-502. PubMed ID: 4801260
    [No Abstract]   [Full Text] [Related]  

  • 13. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC; Kruse A; Kirkegaard C
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 1-dihydroxyphenylalanine (l-dopa), anesthesia and surgical stress on the secretion of growth hormone in the dog.
    Lovinger RD; Connors MH; Kaplan SL; Ganong WF; Grumbach MM
    Endocrinology; 1974 Nov; 95(5):1317-21. PubMed ID: 4426291
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of L-dopa on anterior pituitary hormone release in man.
    Saito S; Abe K; Nagata N; Nakamura E; Tanaka K
    Endocrinol Jpn; 1972 Oct; 19(5):435-42. PubMed ID: 4678853
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J; Límanová Z; Srámková J
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of human-growth-hormone secretion by L-dopa.
    Boyd AE; Lebovitz HE; Pfeiffer JB
    N Engl J Med; 1970 Dec; 283(26):1425-9. PubMed ID: 5481776
    [No Abstract]   [Full Text] [Related]  

  • 18. Species specificity in the TSH response to the administration of L-dopa.
    Tsukui T; Kanno Y; Koizumi Y; Hashizume K; Onaya T
    Proc Soc Exp Biol Med; 1974 Jan; 145(1):346-9. PubMed ID: 4204828
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressive effect of cyproheptadine on L-DOPA-induced growth hormone release in man.
    Nakai Y; Imura H
    Endocrinol Jpn; 1975 Aug; 22(4):357-60. PubMed ID: 1201741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood acromegaly: successful therapy with conventional radiation and effects of chlorpromazine on growth hormone and prolactin secretion.
    AvRuskin TW; Sau K; Tang S; Juan C
    J Clin Endocrinol Metab; 1973 Sep; 37(3):380-8. PubMed ID: 4206490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.